When the words “pancreatic cancer” appear on a diagnostic report—especially when accompanied by “25 liver metastases”—countless families have been plunged into despair. This disease, known as the “king of cancers,” once diagnosed with multiple metastases, often means a survival time measured in “months” or even “weeks.” But today, we want to share a true story from Beijing South Region Oncology Hospital—about a cancer patient from Shandong, China, who regained hope here, lived with a high quality of life for over two years, and is still continuing his life journey.
A late-stage patient once given “six months” has now lived peacefully for two years.
Two years ago, when this patient first arrived at the hospital, his condition was extremely grim: diagnosed with pancreatic cancer, with 25 metastatic lesions densely scattered across his liver, and a tumor marker CA199 level as high as 32,680 U/mL (normal value typically <37 U/mL). According to conventional understanding, late-stage pancreatic cancer with multiple liver metastases has an extremely low six-month survival rate, and treatment options are quite limited both in China and abroad.
However, the expert team at Beijing South Region Oncology Hospital International Department did not give up. Instead of adopting traditional invasive treatments that often cause significant harm to late-stage patients—”losing a thousand of our own to kill eight hundred of the enemy”—they introduced an advanced, green, non-invasive technology: High-Intensity Focused Ultrasound (HIFU).
- One treatment, ablation of 26 lesions: In October 2023, doctors precisely ablated the primary tumor in the pancreatic head and all 25 liver metastases in a single session. The entire procedure was incision-free, bloodless, and required no intubation.
- Normal activity resumed the day after treatment: The therapy had minimal impact on the patient’s immune system, avoiding complications common in late-stage patients such as post-operative infections and poor wound healing.
- Two-year results are astonishing: Recent follow-up examinations show his CA199 has dropped to 5.66—completely normal. PET-CT confirmed that the primary tumor and all liver metastases show no metabolically active disease, meaning the lesions have been successfully “inactivated,” and the disease has remained stable long-term.
Today, this patient has not only survived for more than two years but also enjoys a good quality of life. He even actively shares his anti-cancer journey on Douyin (TikTok).
Why does HIFU open a new door for late-stage cancer patients?
For late-stage cancer patients who are malnourished and have weakened immune systems, traditional surgery, radiotherapy, and chemotherapy often fall short. The advantages of HIFU lie precisely in:
- Non-invasive and green: Focused ultrasound waves from outside the body precisely ablate tumors inside, leaving no wounds on the skin.
- No damage to normal tissue: Minimal impact on the immune system, preserving strength for subsequent combination therapies.
- Able to treat multiple metastases in one session: As long as there is a safe ultrasound pathway, it can “batch-inactivate” metastatic tumors scattered in the liver and elsewhere.
- Rapidly reduces tumor burden: Buying precious time and space for immune system recovery.
As Professor Li Lijun, Director of the HIFU Center at Beijing South Region Oncology Hospital, said when reviewing this case:
> “Multiple liver metastases are no longer a contraindication for HIFU. This case tells us: late-stage does not mean terminal stage. Appropriate local treatment can completely rewrite a patient’s survival curve. As doctors, what we most hope to see is not ‘setting records,’ but patients living long and with quality of life.”
Open to International Patients: Our Doors Are Wide Open
The International Department at Beijing South Region Oncology Hospital is dedicated to providing advanced, compassionate, and personalized treatment options for cancer patients worldwide. Whether you or your loved one is facing pancreatic cancer, liver cancer, soft tissue sarcoma, uterine fibroids, or other solid tumors, our HIFU technology and multidisciplinary treatment system may bring you an unexpected turnaround.
Contact Us Today for a Second Opinion or Treatment Assessment
We offer bilingual services in Chinese and English, assisting international patients with remote consultations, visa invitation letters, admission coordination, and follow-up care.
Phone Consultation
��� 400-880-3716
��� WeChat ID: 17801183037
��� Email 1: 100085_010@163.com
��� Email 2: myimmnet@163.com
Your hope may be just one contact away.
We understand that seeking medical help across borders requires immense courage and trust. But remember: that patient from Shandong stood at the same crossroads two years ago. He chose Beijing South Region Oncology Hospital, chose HIFU, and today he is still living a normal life, still encouraging other patients on Douyin, still proving with his own story that even the “king of cancers” is not invincible.
Don’t wait until tomorrow.
In cancer treatment, timing is critical. No matter what stage you are at, one consultation, one email, one phone call could open a new door to life.
��� 400-880-3716
��� WeChat: 17801183037
��� 100085_010@163.com or myimmnet@163.com
Beijing South Region Oncology Hospital International Department
— Safeguarding the quality of life for cancer patients worldwide with advanced, non-invasive technology.
Post time: Apr-21-2026